Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy

Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy:A Comparative Effectiveness Randomized Control Trial (PRECISE)

The purpose of this study is to evaluate whether Continuous glucose monitoring (CGM) for diagnosis of gestational diabetes mellitus (GDM) improves maternal and neonatal outcomes related to GDM and to evaluate whether CGM for GDM diagnosis reduces the health system costs for mother-infant dyads compared to usual care

Inclusion Criteria:

• 24-30 weeks gestation undergoing GDM screening

Exclusion Criteria:

• Known diagnosis of Type I and II DM
• History of bariatric surgery
• Major fetal anomalies
• Unwilling to use CGM for GDM screening
• Incarcerated subjects
• History of allergic reaction to any of CGM metals or adhesives in contact with the skin